A European trade pact will cost Canadians higher pharmaceutical prices, warns an advocacy group. Critics said the treaty may delay the introduction of low-cost generic drugs: “There’s no give and take; we are giving.”
A European trade pact will cost Canadians higher pharmaceutical prices, warns an advocacy group. Critics said the treaty may delay the introduction of low-cost generic drugs: “There’s no give and take; we are giving.”